메뉴 건너뛰기




Volumn 44, Issue 1, 2016, Pages 22-28

Increased levels of copeptin, a surrogate marker of arginine vasopressin, are associated with an increased risk of chronic kidney disease in a general population

Author keywords

Chronic kidney disease; Copeptin; Epidemiology; Estimated glomerular filtration rate

Indexed keywords

ARGIPRESSIN; COPEPTIN; GLYCOPEPTIDE;

EID: 84976585191     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000447522     Document Type: Article
Times cited : (51)

References (20)
  • 1
    • 29744438811 scopus 로고    scopus 로고
    • Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin
    • Morgenthaler NG, et al. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 2006; 52: 112-119.
    • (2006) Clin Chem , vol.52 , pp. 112-119
    • Morgenthaler, N.G.1
  • 2
    • 0017157624 scopus 로고
    • Distribution, blood transport, and degradation of antidiuretic hormone in man
    • Baumann G, Dingman JF: Distribution, blood transport, and degradation of antidiuretic hormone in man. J Clin Invest 1976; 57: 1109-1116.
    • (1976) J Clin Invest , vol.57 , pp. 1109-1116
    • Baumann, G.1    Dingman, J.F.2
  • 3
    • 84876184092 scopus 로고    scopus 로고
    • Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: The prospective Malmo diet and cancer study cardiovascular cohort
    • Enhorning S, et al. Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmo diet and cancer study cardiovascular cohort. Int J Obes (Lond) 2013; 37: 598-603.
    • (2013) Int J Obes (Lond) , vol.37 , pp. 598-603
    • Enhorning, S.1
  • 4
    • 79960087721 scopus 로고    scopus 로고
    • Plasma copeptin, a unifying factor behind the metabolic syndrome
    • Enhorning S, et al. Plasma copeptin, a unifying factor behind the metabolic syndrome. J Clin Endocrinol Metab 2011; 96:E1065-E1072.
    • (2011) J Clin Endocrinol Metab , vol.96 , pp. E1065-E1072
    • Enhorning, S.1
  • 5
    • 77953124970 scopus 로고    scopus 로고
    • Plasma copeptin and the risk of diabetes mellitus
    • Enhorning S, et al. Plasma copeptin and the risk of diabetes mellitus. Circulation 2010; 121: 2102-2108.
    • (2010) Circulation , vol.121 , pp. 2102-2108
    • Enhorning, S.1
  • 6
    • 84866362758 scopus 로고    scopus 로고
    • Sex differences in the association between plasma copeptin and incident type 2 diabetes: The prevention of renal and vascular endstage disease (PREVEND) study
    • Abbasi A, et al. Sex differences in the association between plasma copeptin and incident type 2 diabetes: the prevention of renal and vascular endstage disease (PREVEND) study. Diabetologia 2012; 55: 1963-1970.
    • (2012) Diabetologia , vol.55 , pp. 1963-1970
    • Abbasi, A.1
  • 7
    • 0033618611 scopus 로고    scopus 로고
    • Contribution of vasopressin to progression of chronic renal failure: Study in Brattleboro rats
    • Bouby N, Hassler C, Bankir L: Contribution of vasopressin to progression of chronic renal failure: study in Brattleboro rats. Life Sci 1999; 65: 991-1004.
    • (1999) Life Sci , vol.65 , pp. 991-1004
    • Bouby, N.1    Hassler, C.2    Bankir, L.3
  • 8
    • 84879964727 scopus 로고    scopus 로고
    • Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33)
    • Boertien WE, et al. Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33). Diabetologia 2013; 56: 1680-1688.
    • (2013) Diabetologia , vol.56 , pp. 1680-1688
    • Boertien, W.E.1
  • 9
    • 84891854098 scopus 로고    scopus 로고
    • Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria
    • Velho G, et al. Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria. Diabetes Care 2013; 36: 3639-3645.
    • (2013) Diabetes Care , vol.36 , pp. 3639-3645
    • Velho, G.1
  • 10
    • 84887622235 scopus 로고    scopus 로고
    • Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31)
    • Riphagen IJ, et al. Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31). Diabetes Care 2013; 36: 3201-3207.
    • (2013) Diabetes Care , vol.36 , pp. 3201-3207
    • Riphagen, I.J.1
  • 11
    • 84927570940 scopus 로고    scopus 로고
    • Copeptin is an independent predictor of diabetic heart disease and death
    • Enhorning S, et al. Copeptin is an independent predictor of diabetic heart disease and death. Am Heart J 2015; 169: 549-556.e1.
    • (2015) Am Heart J , vol.169 , pp. 549-549e1
    • Enhorning, S.1
  • 12
    • 84958981346 scopus 로고    scopus 로고
    • Copeptin predicts coronary artery disease cardiovascular and total mortality
    • Tasevska I, et al. Copeptin predicts coronary artery disease cardiovascular and total mortality. Heart 2016; 102: 127-132.
    • (2016) Heart , vol.102 , pp. 127-132
    • Tasevska, I.1
  • 13
    • 84923800132 scopus 로고    scopus 로고
    • Kidney function and plasma copeptin levels in healthy kidney donors and autosomal dominant polycystic kidney disease patients
    • Zittema D, et al. Kidney function and plasma copeptin levels in healthy kidney donors and autosomal dominant polycystic kidney disease patients. Clin J Am Soc Nephrol 2014; 9: 1553-1562.
    • (2014) Clin J Am Soc Nephrol , vol.9 , pp. 1553-1562
    • Zittema, D.1
  • 14
    • 18044365616 scopus 로고    scopus 로고
    • Incident coronary events and case fatality in relation to common carotid intima-media thickness
    • Rosvall M, et al. Incident coronary events and case fatality in relation to common carotid intima-media thickness. J Intern Med 2005; 257: 430-437.
    • (2005) J Intern Med , vol.257 , pp. 430-437
    • Rosvall, M.1
  • 15
    • 0033574249 scopus 로고    scopus 로고
    • A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in renal disease study group
    • Levey AS, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999; 130: 461-470.
    • (1999) Ann Intern Med , vol.130 , pp. 461-470
    • Levey, A.S.1
  • 16
    • 84863524855 scopus 로고    scopus 로고
    • Estimating glomerular filtration rate from serum creatinine and cystatin C
    • Inker LA, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012; 367: 20-29.
    • (2012) N Engl J Med , vol.367 , pp. 20-29
    • Inker, L.A.1
  • 17
    • 84941247629 scopus 로고    scopus 로고
    • Plasma copeptin and decline in renal function in a cohort from the community: The prospective D.E.S.I.R. Study
    • Roussel R, et al. Plasma copeptin and decline in renal function in a cohort from the community: the prospective D.E.S.I.R. study. Am J Nephrol 2015; 42: 107-114.
    • (2015) Am J Nephrol , vol.42 , pp. 107-114
    • Roussel, R.1
  • 18
    • 0041883699 scopus 로고    scopus 로고
    • Diabetes-induced albuminuria: Role of antidiuretic hormone as revealed by chronic V2 receptor antagonism in rats
    • Bardoux P, et al. Diabetes-induced albuminuria: role of antidiuretic hormone as revealed by chronic V2 receptor antagonism in rats. Nephrol Dial Transplant 2003; 18: 1755-1763.
    • (2003) Nephrol Dial Transplant , vol.18 , pp. 1755-1763
    • Bardoux, P.1
  • 19
    • 0025209989 scopus 로고
    • Effect of water intake on the progression of chronic renal failure in the 5/6 nephrectomized rat
    • Bouby N, et al. Effect of water intake on the progression of chronic renal failure in the 5/6 nephrectomized rat. Am J Physiol 1990; 258(4 pt 2):F973-F979.
    • (1990) Am J Physiol , vol.258 , Issue.4 , pp. F973-F979
    • Bouby, N.1
  • 20
    • 85013000324 scopus 로고    scopus 로고
    • Effect of tolvaptan in autosomal dominant polycystic kidney disease by CKD stage: Results from the TEMPO 3: 4 trial
    • Torres VE, et al. Effect of tolvaptan in autosomal dominant polycystic kidney disease by CKD stage: results from the TEMPO 3: 4 trial. Clin J Am Soc Nephrol 2016; 11: 803-811.
    • (2016) Clin J Am Soc Nephrol , vol.11 , pp. 803-811
    • Torres, V.E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.